Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -7.77M | -157.14% | $ 4.94M |
3/31/2025 | $ -7.02M | -142.61% | $ 4.92M |
12/31/2024 | $ -7.29M | -150.92% | $ 4.83M |
9/30/2024 | $ -6.64M | -133.83% | $ 4.96M |
6/30/2024 | $ -6.99M | -151.94% | $ 4.6M |
3/31/2024 | $ -6.61M | -117.58% | $ 5.63M |
12/31/2023 | $ -6.34M | -115.49% | $ 5.49M |
9/30/2023 | $ -7.2M | -152.69% | $ 4.72M |
6/30/2023 | $ -7.28M | -176.11% | $ 4.14M |
3/31/2023 | $ -10.67M | -456.24% | $ 2.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for INMED PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -9.79M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]
Minimum
Dec 31, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |